COMMON STOCK | At September 30, 2016, the Company's authorized capital stock was 150,000,000 shares of common stock, par value $0.001 per share, and 10,000,000 shares of preferred stock, par value $0.001 per share. On that date, the Company had outstanding 42,948,265 shares of common stock, and no shares of preferred stock. 2016 Transactions · 437,500 shares of common stock for current services rendered and prior services which had previously been recorded as stocks payable totaling $98,810 or $0.23 per share (average cost). 2015 Transactions · 616,659 shares of common stock issued for various services valued at $199,805. · 12,500 shares of common stock for prior services which had previously been recorded as accrued liability for $2,694 in 2014. · 200,000 shares of common stock for prior services which had previously been recorded as accrued liability for $65,211 or $0.18 per share. · 5,000,000 shares of common stock issued related to a previously recorded stock payable for $680,000 or $0.14 per share. Stock and Warrant Grants: In March 2015, the Company granted 200,000 shares of common stock along with 200,000 warrants to a consultant. The shares were valued at $30,600 or $0.16 per share (including a 15% discount of fair market value due to these shares being restricted and lacking market liquidity). The warrants were valued at $34,611, using the Black-Scholes options pricing model under the following assumptions: stock price at issuance of $0.18 per share; exercise price of $0.25, 3 year life; discount rate of 2.00%; and volatility rate of 245%. The 200,000 shares and 200,000 warrants granted have a vesting period of six months and were fully vested as of September 30, 2016. The approximate value vested during the three and nine months ended September 30, 2015 was $28,000 and $62,000. As of September 30, 2016, the 200,000 shares and 200,000 warrants granted have been issued. In August 2014, the Company granted 150,000 shares of common stock to a consultant with a total value of $25,500 or $0.17 per share (including a 15% discount of fair market value due to these shares being restricted and lacking market liquidity). The 150,000 shares granted have a vesting period of three years of which twenty six months have vested as of September 30, 2016. The approximate value vested for the three and nine months ended September 30, 2015 and 2016 were $2,000 and $6,000, and $2,100 and $6,300 respectively. As of September 30, 2016, 100,000 shares granted have been issued. In September 2014, the Company granted 150,000 shares of common stock along with 150,000 Class A warrants and 150,000 Class B warrants to an advisory board member. The shares were valued at $19,250 or $0.13 per share (including a 15% discount of fair market value due to these shares being restricted and lacking market liquidity. The warrants were valued at $42,761, using the Black-Scholes options pricing model under the following assumptions: stock price at issuance of $0.15 per share; exercise price of $0.25 for the Class A warrants and $0.50 for the Class B warrants, 3 year life; discount rate of 2.00 %; and volatility rate of 245%. The 150,000 shares and 300,000 warrants granted vest over a 3 year period, at 50,000 shares and 100,000 warrants per year of which twenty five months have vested as of September 30, 2016. The approximate value vested for the three and nine months ended September 30, 2015 and 2016 were $5,000 and $15,000, and $5,100 and $15,300, respectively. As of September 30, 2016, none of the 150,000 shares or 300,000 warrants granted have been issued. In September 2014, the Company granted 200,000 shares of common stock along with 200,000 warrants to a consultant. The shares were valued at $30,600 or $0.16 per share (including a 15% discount of fair market value due to these shares being restricted and lacking market liquidity). The warrants were valued at $34,611, using the Black-Scholes options pricing model under the following assumptions: stock price at issuance of $0.18 per share; exercise price of $0.25, 3 year life; discount rate of 2.00 %; and volatility rate of 245%. The 150,000 shares and 200,000 warrants granted have a vesting period of six months and were fully vested as September 30, 2016. During the nine months ended September 30, 2016, the company issued the 200,000 shares and warrant for 200,000 shares of common stock. On October 17, 2014, the Company granted 150,000 shares of common stock to an advisory board member with a total value of $32,400 or $0.21 per share (including a 10% discount of fair market value due to these shares being restricted and lacking market liquidity). The 150,000 shares granted vest over a 3 year period, at 50,000 shares per year of which twenty three months have vested as of September 30, 2016. The approximate value vested for the three and nine months ended September 30, 2015 and 2016 were $3,000 and $8,000, and $2,700 and $8,100, respectively. As of September 30, 2016, 87,500 of the shares previously vested have been issued and the remaining 62,500 shares granted have not been issued. In October 2013, the Company granted 300,000 shares of common stock to an employee of the Company with a total value of $38,250 or $0.15 per share (including a 15% discount of fair market value due to these shares being restricted and lacking market liquidity). The 300,000 shares granted have a vesting period of three years of which all have been fully vested as of September 30, 2016. The approximate value vested for the three and nine months ended September 30, 2016 and 2015 was $3,000 and $9,000, respectively. A payable has been recorded for the vested amount that remains unissued as of September 30, 2016. As of September 30, 2016, 200,000 shares granted have been issued. In November 2014, the Company issued a warrant for 100,000 shares of common stock as part of an issuance of note payable totaling $100,000. The warrant has an exercise price of $0.50 and life of three years. In August 2012, the Company granted a total of 5,000,000 shares of common stock to various officers and directors of the Company with a total value of $680,000 or $0.14 per share (including a 15% discount of fair market value due to these shares being restricted and lacking market liquidity). The 5,000,000 shares granted had a vesting period of five years of which all have been fully vested as of December 31, 2014. The approximate value vested for the year ended December 31, 2014 was $680,000 for which a payable had been recorded for the same amount as of December 31, 2014. The shares were issued in the quarter ending June 30, 2015. |